Baxter Total Liabilities 2010-2025 | BAX

Baxter total liabilities from 2010 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Baxter total liabilities for the quarter ending March 31, 2025 were $18.758B, a 5.3% decline year-over-year.
  • Baxter total liabilities for 2024 were $18.758B, a 5.3% decline from 2023.
  • Baxter total liabilities for 2023 were $19.808B, a 11.54% decline from 2022.
  • Baxter total liabilities for 2022 were $22.392B, a 8.23% decline from 2021.
Baxter Annual Total Liabilities
(Millions of US $)
2024 $18,758
2023 $19,808
2022 $22,392
2021 $24,400
2020 $11,293
2019 $10,281
2018 $7,854
2017 $7,995
2016 $7,266
2015 $12,097
2014 $17,982
2013 $16,738
2012 $13,412
2011 $12,245
2010 $10,693
2009 $9,934
Baxter Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $18,758
2024-09-30 $18,734
2024-06-30 $18,604
2024-03-31 $19,553
2023-12-31 $19,808
2023-09-30 $22,490
2023-06-30 $22,254
2023-03-31 $22,350
2022-12-31 $22,392
2022-09-30 $22,386
2022-06-30 $22,928
2022-03-31 $23,597
2021-12-31 $24,400
2021-09-30 $10,992
2021-06-30 $11,147
2021-03-31 $10,976
2020-12-31 $11,293
2020-09-30 $11,496
2020-06-30 $11,305
2020-03-31 $11,345
2019-12-31 $10,281
2019-09-30 $9,682
2019-06-30 $9,708
2019-03-31 $8,681
2018-12-31 $7,854
2018-09-30 $7,734
2018-06-30 $7,709
2018-03-31 $7,797
2017-12-31 $7,995
2017-09-30 $8,082
2017-06-30 $7,798
2017-03-31 $6,984
2016-12-31 $7,266
2016-09-30 $7,131
2016-06-30 $7,472
2016-03-31 $8,330
2015-12-31 $12,097
2015-09-30 $12,327
2015-06-30 $21,994
2015-03-31 $17,573
2014-12-31 $17,982
2014-09-30 $17,137
2014-06-30 $16,942
2014-03-31 $16,568
2013-12-31 $16,738
2013-09-30 $17,504
2013-06-30 $16,436
2013-03-31 $13,317
2012-12-31 $13,412
2012-09-30 $12,635
2012-06-30 $11,834
2012-03-31 $11,820
2011-12-31 $12,245
2011-09-30 $10,653
2011-06-30 $10,497
2011-03-31 $10,442
2010-12-31 $10,693
2010-09-30 $10,800
2010-06-30 $10,353
2010-03-31 $10,507
2009-12-31 $9,934
2009-09-30 $9,643
2009-06-30 $8,969
2009-03-31 $8,795
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $15.731B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $227.710B 27.38
Boston Scientific (BSX) US $152.625B 38.22
Stryker (SYK) US $142.748B 29.85
EssilorLuxottica (ESLOY) FR $131.899B 0.00
Medtronic (MDT) IE $107.169B 15.65
Lonza Group Ag (LZAGY) CH $51.526B 0.00
Haleon (HLN) GB $46.608B 26.49
ResMed (RMD) US $34.676B 26.05
GE HealthCare Technologies (GEHC) US $30.985B 14.71
Agilent Technologies (A) US $30.352B 20.05
Terumo (TRUMY) JP $28.456B 0.00
Koninklijke Philips (PHG) NL $23.480B 16.76
Zimmer Biomet Holdings (ZBH) US $20.144B 12.73
Insulet (PODD) US $17.608B 75.15
Smith & Nephew SNATS (SNN) GB $12.359B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.600B 0.00
Lantheus Holdings (LNTH) US $7.253B 17.83
Bio-Rad Laboratories (BIO) US $6.735B 22.77
Prestige Consumer Healthcare (PBH) US $4.074B 19.44
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Perrigo (PRGO) IE $3.448B 9.87
ICU Medical (ICUI) US $3.371B 28.72
Haemonetics (HAE) US $3.164B 14.89
Envista Holdings (NVST) US $2.769B 23.01
LeMaitre Vascular (LMAT) US $2.039B 45.58
GN Store Nord (GNNDY) DK $1.930B 15.99
QuidelOrtho (QDEL) US $1.881B 15.75
AtriCure (ATRC) US $1.450B 0.00
Green Thumb Industries (GTBIF) US $1.325B 20.87
Kestra Medical Technologies (KMTS) US $1.179B 0.00
BioLife Solutions (BLFS) US $1.169B 0.00
AdaptHealth (AHCO) US $1.146B 11.04
Neogen (NEOG) US $1.118B 14.31
InMode (INMD) IL $1.023B 9.36
Evolus (EOLS) US $0.761B 0.00
Phibro Animal Health (PAHC) US $0.753B 11.55
Curaleaf Holdings (CURLF) CA $0.649B 0.00
CeriBell (CBLL) US $0.587B 0.00
Capricor Therapeutics (CAPR) US $0.582B 0.00
Owens & Minor (OMI) US $0.538B 4.59
Valneva SE (VALN) FR $0.534B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.516B 0.00
Tilray Brands (TLRY) CA $0.489B 0.00
Cresco Labs (CRLBF) US $0.446B 0.00
Omeros (OMER) US $0.409B 0.00
Surmodics (SRDX) US $0.398B 0.00
SNDL (SNDL) CA $0.371B 0.00
SEMPERIT AG HLD (SEIGY) AT $0.350B 0.00
VAREX IMAGING (VREX) US $0.346B 14.98
Sanara MedTech (SMTI) US $0.287B 0.00
Verano Holdings (VRNOF) US $0.280B 0.00
Viemed Healthcare (VMD) US $0.279B 25.21
Aurora Cannabis (ACB) CA $0.267B 47.50
Canopy Growth (CGC) CA $0.259B 0.00
ZimVie (ZIMV) US $0.252B 15.07
Sanuwave Health (SNWV) US $0.249B 0.00
Cerus (CERS) US $0.249B 0.00
OraSure Technologies (OSUR) US $0.228B 0.00
Quanterix (QTRX) US $0.224B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.179B 4.09
Utah Medical Products (UTMD) US $0.171B 13.81
Brainsway (BWAY) IL $0.166B 51.82
TriSalus Life Sciences (TLSI) US $0.164B 0.00
FitLife Brands (FTLF) US $0.144B 17.77
Organigram Global (OGI) CA $0.144B 0.00
Jin Medical (ZJYL) CN $0.125B 0.00
Agape ATP (ATPC) $0.117B 0.00
TerrAscend (TSNDF) CA $0.114B 0.00
Exagen (XGN) US $0.111B 0.00
MacroGenics (MGNX) US $0.106B 0.00
Oramed Pharmaceuticals (ORMP) US $0.093B 0.00
Quipt Home Medical (QIPT) US $0.092B 0.00
Veru (VERU) US $0.077B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
InterCure (INCR) IL $0.071B 0.00
Cytosorbents (CTSO) US $0.063B 0.00
United Health Products (UEEC) US $0.062B 0.00
Zynex (ZYXI) US $0.061B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Modular Medical (MODD) US $0.042B 0.00
Apyx Medical (APYX) US $0.040B 0.00
Safety Shot (SHOT) US $0.039B 0.00
United-Guardian (UG) US $0.037B 11.41
Rockwell Medical (RMTI) US $0.037B 54.00
Nephros (NEPH) US $0.019B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.014B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00